Of note, a TGFβ-dependent stromal subset was recently characterised within MSI-H/dMMR CRC, exhibiting an increase in both angiogenesis and tumour neovasculature, as well as abnormal control of ECM remodelling. The gene discussed is TGFB1; the disease is neoplasm.